SCHEMBL10126570

SCHEMBL10126570

Nc1cc(S(=O)(=O)N2CCCCC2)ccc1F

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.66
HTT P42858 4/20 0.62
ALDH1A1 P00352 3/20 0.62
MAPT P10636 2/20 0.62
CYP3A4 P08684 1/20 0.62
MITF O75030 1/20 0.62
LMNA P02545 1/20 0.62
GAA P10253 1/20 0.62
NPSR1 Q6W5P4 1/20 0.62
TSHR P16473 2/20 0.59
USP2 O75604 1/20 0.59
KDM4E B2RXH2 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
MCOLN3 Q8TDD5 2/20 0.54
L3MBTL1 Q9Y468 1/20 0.53
POLB P06746 1/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
VDR P11473 1/20 0.51
HPGD P15428 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4555850 0.85 ALDH1A1 (0.68) HTTALDH1A1MAPTCYP3A4MITF
SCHEMBL11668435 0.81 RAB9A (0.66) RAB9AHTTALDH1A1MAPTLMNA
SCHEMBL9796209 0.81 ALDH1A1 (0.67) RAB9AHTTALDH1A1LMNANPSR1
SCHEMBL424742 0.80 ALDH1A1 (0.60) HTTALDH1A1MAPTCYP3A4MITF
SCHEMBL4894531 0.79 RAB9A (0.63) RAB9AHTTALDH1A1MAPTGAA
SCHEMBL15067563 0.79 ALDH1A1 (0.60) HTTALDH1A1MAPTCYP3A4MITF
SCHEMBL1746018 0.77 RAB9A (0.61) RAB9AHTTALDH1A1MAPTLMNA
SCHEMBL14501796 0.77 HSD17B10 (0.60) HTTALDH1A1MAPTCYP3A4MITF
SCHEMBL24263764 0.77 MCOLN3 (0.70) RAB9AHTTALDH1A1LMNATSHR
SCHEMBL22116077 0.77 MCOLN3 (0.70) RAB9AHTTALDH1A1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9487491-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2016-11-08 US disclosed
US-9487491-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2016-11-08 US disclosed
US-8969336-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2015-03-03 US disclosed
US-8969336-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2015-03-03 US disclosed
US-20140371196-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND ASTELLAS PHARMA INC. (JP) 2014-12-18 US disclosed
US-20140371196-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND ASTELLAS PHARMA INC. (JP) 2014-12-18 US disclosed
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND WATERS TECHNOLOGIES CORPORATION (US) 2012-02-16 US disclosed
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND WATERS TECHNOLOGIES CORPORATION (US) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140371196-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND EML4, ALK, ERBB4 RAB9A 1850/4885HTT 3739/4885ALDH1A1 1554/4885
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND EML4, ALK, ERBB4 RAB9A 1850/4885HTT 3739/4885ALDH1A1 1554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.